Human CD19 VLP (CD1-HM09V)

Produktübersicht

• Artikelname: Human CD19 VLP (CD1-HM09V)
• Artikelnummer: KAB-CD1-HM09V
• Hersteller Artikelnummer: CD1-HM09V
• Alternativnummer: KAB-CD1-HM09V-100UG
• Hersteller: KactusBio
• Kategorie: Sonstiges
• Spezies Reaktivität: Human
• Alternative Synonym: CD19, B4, CVID3, Leu-12, MGC12802

Produktbeschreibung

Human CD19 VLP is expressed from HEK293. It contains Met1-Arg556 (It may have cross reaction with anti-His antibody).

Produkteigenschaften

• Molekulargewicht: The target protein has a predicted MW of 62.04 kDa.
• UniProt: P15391
• Puffer: Supplied as 0.22 µm filtered solution in PBS, 300mM L-arginine (pH 7.4). <RED>Notice: If you need it for immunization, water-soluble adjuvant is recommended.</RED&gt
• Expression System: HEK293
• Reinheit: > 95% as determined by HPLC
• Formulierung: Liquid
• Sequenz: Met1-Arg556
• Target-Kategorie: CD19

Bilder

The purity of Human CD19 VLP is greater than 95% as determined by SEC-HPLC.

Immobilized Human CD19 VLP at 2 ug/ml (100ul/well) on the plate. Dose response curve for Coltuximab, hFc Tag with the EC50 of 4.9ng/ml determined by ELISA.

Immobilized Human CD19 VLP at 2ug/ml (100ul/well) on the plate. Dose response curve for FMC63, mFc Tag with the EC50 of 4.0/-ng/ml determined by ELISA.

Immobilized Human CD19 VLP at 2ug/ml (100ul/well) on the plate. Dose response curve for Inebilizumab, hFc Tag with the EC50 of 4.3ng/ml determined by ELISA.

Immobilized Human CD19 VLP at 2ug/ml (100ul/well) on the plate. Dose response curve for Denintuzumab, hFc Tag with the EC50 of 10.9ng/ml determined by ELISA.